Rutgers: Methadone Use in Early Pregnancy May Lead to More Birth Defects Than Buprenorphine
February 06, 2024
February 06, 2024
NEW BRUNSWICK, New Jersey, Feb. 6 (TNSres) -- Rutgers University issued the following news:
By Andrew Smith
Researchers from Rutgers Health and Harvard Medical School have found fewer congenital defects in children whose mothers treated opioid use disorder with buprenorphine rather than methadone during the first trimester of pregnancy.
The study findings extend those from a previous study from the same research group, which found fewer preterm births and f . . .
By Andrew Smith
Researchers from Rutgers Health and Harvard Medical School have found fewer congenital defects in children whose mothers treated opioid use disorder with buprenorphine rather than methadone during the first trimester of pregnancy.
The study findings extend those from a previous study from the same research group, which found fewer preterm births and f . . .